Leptin selectively decreases visceral adiposity and enhances insulin action. - Wikidata - awgldk - TriplyDB

Leptin selectively decreases visceral adiposity and enhances insulin action.

Leptin selectively decreases visceral adiposity and enhances insulin action.

http://www.wikidata.org/entity/Q37376534

about

Resistin in dairy cows: plasma concentrations during early lactation, expression and potential role in adipose tissue Role of visceral adipose tissue in aging Relationships between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism In vivo screening for secreted proteins that modulate glucose handling identifies interleukin-6 family members as potent hypoglycemic agents Living without insulin: the role of leptin signaling in the hypothalamus Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies Central melanocortin receptors regulate insulin action Insulin increases central apolipoprotein E levels as revealed by an improved technique for collection of cerebrospinal fluid from rats Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle Disorders of glucose metabolism in sleep apnea.Optimal Pharmacologic Treatment Strategies in Obesity and Type 2 Diabetes The brain is the conductor: diet-induced inflammation overlapping physiological control of body mass and metabolism.SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELS Artificial neural networks based controller for glucose monitoring during clamp test Decreased triglyceride-rich lipoproteins in transgenic skinny mice overexpressing leptin.The role of leptin in glucose homeostasis.Sleep and diabetes.Insufficiency of Janus kinase 2-autonomous leptin receptor signals for most physiologic leptin actions Pharmacotherapy of type 2 diabetes mellitus.Counterregulation of insulin by leptin as key component of autonomic regulation of body weight.Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats.Searching for human longevity genes: the future history of gerontology in the post-genomic era.Differential effects of hypothalamic long-chain fatty acid infusions on suppression of hepatic glucose production.Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats.Adipose tissue promotes a serum cytokine profile related to lower insulin sensitivity after chronic central leptin infusion Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea Decreased food intake with aging.Role of leptin in glucose metabolism in type 2 diabetes.Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats.Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome Diabetes, lipids, and adipocyte secretagogues.Critical role of STAT3 in leptin's metabolic actions.Thematic review series: adipocyte biology. Sympathetic and sensory innervation of white adipose tissue.Enhanced activation of a "nutrient-sensing" pathway with age contributes to insulin resistance.Present and future therapeutic strategies in non-alcoholic fatty liver disease.Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms.Leptin augments the acute suppressive effects of insulin on hepatic very low-density lipoprotein production in rats.

P2860

Q24293157-641ED6FC-279F-4666-AFC8-F3D04034AC6E Q24654243-C83C948A-59E1-48F4-9CEF-EE654FD8AA31 Q26752318-B7665220-1556-4222-9F5D-23BD52DB1ECE Q26864148-6FA426AD-6DAD-438D-8BDA-99A82E8E50B7 Q27320049-64216D60-A0DF-4D94-9A6C-6B0C43A470B3 Q28087133-12AE8970-0983-4D3D-B291-4F7D30DA3A67 Q28088325-1F575556-BFA1-4127-8F9E-48E51B3DAD2F Q28360753-F87E4986-5538-4E33-8C7E-1E90614B7760 Q28568368-5E2F4D91-45DC-4F23-99B4-AD1A69AE2E6B Q28572981-02ABFD9C-3863-43CD-A776-4FA5F48FA8EA Q30351634-B2CDC920-8781-4E4A-8B94-C49F128097D5 Q30377441-E9C97C46-4B65-46A8-A910-AC0525611663 Q30377466-B3585DA3-6145-4F7C-BDED-C2EF3169CDB9 Q30494316-C30F001D-DBDA-4212-9E35-F0BD1E3A1112 Q31089454-70194D42-7960-4C76-9DAB-F1EAF64428F4 Q31833562-EA4566E2-E57D-4916-84BA-5DD53A9D8DBA Q33609782-0E530F66-0178-4B53-AC7F-EB07A578AAB4 Q33717848-0CFBE15D-648D-48C8-9F6D-9F014092835B Q33750675-844E295D-CC4E-4D48-B1FC-174CFA2428C3 Q33992531-059EABE5-39E1-4690-B130-79601B56D49F Q34068418-92B047FF-6E0F-4524-8382-34934BA75B6F Q34113073-CC8C2DE0-4B2E-4416-A99E-D1B6B8C2C8D0 Q34159035-352DD7DC-22E1-4719-8719-8C606BCB563F Q34215237-51DA59FD-C15F-4576-AEBC-9DE603C6D1AC Q34435140-5618B797-544A-45DF-BC0C-8CEE2ED56D61 Q34442433-4E766D4E-F000-48D0-B40D-A2AAA02BCB3A Q34447691-EAB46BA3-1718-4FD8-92AB-0C911B9BE2E9 Q34454676-82F7B04B-5987-4AA0-8FC5-8B2D996A1012 Q34669326-B96F92F4-56CA-4605-895D-90F59BC3D85D Q35197970-A63FCB23-7486-438C-932F-A407B0C39ECA Q35535129-256F2B32-16B8-4156-BF61-F733ACDAAC81 Q35723496-A023B231-CB33-425D-BB15-13321B40881B Q36800063-FCE16226-998C-418F-A3B7-C1BEAB53BA19 Q36802207-8BFECFED-4EB7-4E7C-9CDC-9E4AED825889 Q36879400-15AC5FF5-2A18-4B0F-92D5-2D1827DF8A94 Q36936358-E3E087FE-7EE7-402A-8678-ED6BEF763574 Q36992552-41683C5E-21AD-4F6D-9221-FA588BB79350 Q37077157-4AE88EFF-C3A5-4DAF-90FF-357CA7600233 Q37165803-C3FD55C2-EE67-4601-B0B6-4F9BB7C0E752 Q37166048-446CB2F6-91DE-4257-93BD-5FAAB3357152

P2860

Leptin selectively decreases visceral adiposity and enhances insulin action.

http://www.wikidata.org/entity/Q37376534

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh-hant

name

Leptin selectively decreases visceral adiposity and enhances insulin action.

@en

Leptin selectively decreases visceral adiposity and enhances insulin action.

@nl

type

label

Leptin selectively decreases visceral adiposity and enhances insulin action.

@en

Leptin selectively decreases visceral adiposity and enhances insulin action.

@nl

prefLabel

Leptin selectively decreases visceral adiposity and enhances insulin action.

@en

Leptin selectively decreases visceral adiposity and enhances insulin action.

@nl

P1433

Q37376534-489304CA-1A91-46DE-B52F-6DC387ADFCC8

P1476

Q37376534-D904DF03-8FAD-434F-9AAA-F1A71F29A763

P2093

Q37376534-1B87D596-AD01-4991-A6AC-C35166090EB0

Q37376534-99B8A82D-0E7D-4AB0-98C9-E1A8E79A0A23

Q37376534-99F85F8D-087C-4CF6-A364-19B2EFCADE99

Q37376534-D876DE31-7287-4AD0-A0E6-D7B60F2FE8C9

Q37376534-EC23CEB5-4516-44B2-B911-5B17C55FE607

P2860

Q37376534-0A0B9E59-28B4-47DE-8B1E-79B3A92FD34A

Q37376534-0DFBBEAE-D378-4A74-A47A-19EB9A3A2AFE

Q37376534-0F3D2002-76D4-4CD6-991D-CD4FF246E115

Q37376534-12DE01FF-F307-4F89-B472-8971E30E2B34

Q37376534-177B8F03-0EAD-46D2-B19D-10FDD85E14BE

Q37376534-1F77B737-C57A-4744-841E-2D70930E8117

Q37376534-1F7CA6FA-40A4-4BAB-B0AF-C058FEE2C4BA

Q37376534-3439633A-F801-43AB-A16C-456F2F3E7FB6

Q37376534-59D4E3E1-368F-4BF6-9C7E-1D675DC66AA1

Q37376534-5CD232D9-6BA7-430E-9564-74175E97A2F4

P304

Q37376534-8C6040FC-7E07-4B27-ABD3-5D6C6D011494

P31

Q37376534-F348F8C4-B402-4B8E-AB1A-F31F1E310748

P356

Q37376534-B5F7B885-2CFF-4D5B-A573-1707F75AF4F9

P407

Q37376534-A96DBBB3-6800-499C-A97E-F541C1DE4D71

P433

Q37376534-630C4588-801F-4153-8985-DC70E19DFD4B

P478

Q37376534-F0EDD79E-ABBB-4D3A-BAE6-9BBC07471A81

P50

Q37376534-81E38536-CB96-4153-A2DD-E14C917B5A25

P577

Q37376534-C75BB457-C9EB-4AA1-9323-9C6AA281CC34

P5875

Q37376534-150A45D7-672E-42BF-8DA9-28FA4FAE5EFA

P698

Q37376534-99CF7ED9-97E1-4C31-AC57-6B4249F1CE16

P921

Q37376534-511E5524-FD39-4B7B-B168-B22CFC68A3B4

P932

Q37376534-BF9F3917-D976-4146-9222-D4DBB68EFECA

P356

P1433

Journal of Clinical Investigation

P1476

Leptin selectively decreases visceral adiposity and enhances insulin action

@en

P2093

D Massilon

http://www.w3.org/2001/XMLSchema#string

J Wang

http://www.w3.org/2001/XMLSchema#string

L Rossetti

http://www.w3.org/2001/XMLSchema#string

M Hawkins

http://www.w3.org/2001/XMLSchema#string

N Barzilai

http://www.w3.org/2001/XMLSchema#string

P2860

Positional cloning of the mouse obese gene and its human homologue

Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats

Weight-reducing effects of the plasma protein encoded by the obese gene

Effects of the obese gene product on body weight regulation in ob/ob mice

Identification and expression cloning of a leptin receptor, OB-R

Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.

Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action.

Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.

Recombinant ob protein reduces feeding and body weight in the ob/ob mouse.

Direct antidiabetic effect of leptin through triglyceride depletion of tissues.

P304

3105-3110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI119865

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Patricia M Vuguin

P577

1997-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13830114

http://www.w3.org/2001/XMLSchema#string

P698

9399957

http://www.w3.org/2001/XMLSchema#string

P921

P932

508523

http://www.w3.org/2001/XMLSchema#string